Anoro Ellipta vs. Breo Ellipta

• Are Breo Ellipta and Anoro Ellipta the Same Thing?
• What Are Possible Side Effects of Anoro Ellipta?
• What Are Possible Side Effects of Breo Ellipta?
• What is Anoro Ellipta?
• What is Breo Ellipta?
• What Drugs Interact with Anoro Ellipta?
• What Drugs Interact with Breo Ellipta?
• How Should Anoro Ellipta Be Taken?
• How Should Breo Ellipta Be Taken?

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder and Breo Ellipta (fluticasone furoate and vilanterol) are used to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Breo Ellipta is also used to reduce exacerbations (sudden worsening) of COPD in patients with a history of exacerbations.

Anoro Ellipta and Breo Ellipta both contain a long acting beta-adrenoceptor agonist (LABA). Anoro Ellipta also contains an anticholinergic and Breo Ellipta also contains a corticosteroid.

Side effects of Anoro Ellipta and Breo Ellipta that are similar include sore throat, sinusitis, respiratory tract infection, and cough.

Side effects of Anoro Ellipta that are different from Breo Ellipta include constipation, diarrhea, pain in extremities, muscle spasms, neck pain, chest pain or discomfort, indigestion, abdominal pain, gastroesophageal reflux disease (GERD), vomiting, weakness, irregular heartbeats, itching, rash, conjunctivitis, palpitations, hypersensitivity reactions including anaphylaxis and hives, changes in taste, tremor, and anxiety.

Side effects of Breo Ellipta that are different from Anoro Ellipta include runny nose, headache, oral candidiasis (thrush in your mouth or throat), back pain, pneumonia, bronchitis, mouth pain, joint pain, influenza, and fever.

Both Anoro Ellipta Breo Ellipta and may interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta-blockers, and diuretics (water pills).

Anoro Ellipta may also interact with other anticholinergic drugs.

Breo Ellipta may also interact with antifungal medications containing ketoconazole.

 

Common side effects of Anoro Ellipta include:

• sore throat,
• sinusitis,
• respiratory tract infection,
• constipation,
• diarrhea,
• pain in extremities,
• muscle spasms,
• neck pain,
• chest pain or discomfort,
• cough,
• indigestion,
• abdominal pain,
• gastroesophageal reflux disease (GERD),
• vomiting,
• weakness,
• irregular heart beats,
• itching,
• rash,
• conjunctivitis,
• palpitations,
• hypersensitivity reactions including anaphylaxis and hives,
• changes in taste,
• tremor, and
• anxiety.

Common side effects of Breo Ellipta include:

• upper respiratory tract infection,
• runny nose,
• sore throat,
• headache,
• oral candidiasis (thrush in your mouth or throat),
• back pain,
• pneumonia,
• bronchitis,
• sinus infection,
• cough,
• mouth pain,
• joint pain,
• influenza,
• sore throat, and
• fever.

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder is a combination anticholinergic and long acting beta-adrenoceptor agonist (LABA) used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Breo Ellipta combines an inhaled corticosteroid (ICS) medicine, fluticasone furoate, and a LABA medicine, vilanterol.

ICS medicines such as fluticasone furoate help to decrease inflammation in the lungs. Inflammation in the lungs can lead to breathing problems.

LABA medicines such as vilanterol help the muscles around the airways in your lungs stay relaxed to prevent symptoms, such as wheezing, cough, chest tightness, and shortness of breath. These symptoms can happen when the muscles around the airways tighten. This makes it hard to breathe.

Breo Ellipta should not be used in children and adolescents. It is not known if Breo Ellipta is safe and effective in children and adolescents younger than 18 years of age.

Breo Ellipta is used for COPD and asthma and as follows:

• Breo Ellipta 100/25 is a prescription medicine used to treat COPD. COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both. Breo Ellipta 100/25 is used long term as 1 inhalation 1 time each day to improve symptoms of COPD for better breathing and to reduce the number of flare-ups (the worsening of your COPD symptoms for several days).
• Breo Ellipta is not used to relieve sudden breathing problems and will not replace a rescue inhaler.
• Breo Ellipta is a prescription medicine used as 1 inhalation 1 time each day to prevent and control symptoms of asthma for better breathing and to prevent symptoms such as wheezing.
• Breo Ellipta contains vilanterol. LABA medicines such as vilanterol increase the risk of death from asthma problems.
• Breo Ellipta is not for people with asthma who are well controlled with an asthma control medicine, such as a low to medium dose of an inhaled corticosteroid medicine.
• Breo Ellipta is not used to relieve sudden breathing problems and will not replace a rescue inhaler.

Anoro Ellipta may interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta blockers, diuretics, and other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Anoro Ellipta should be used only if prescribed. Tell your doctor if you are pregnant before taking Anoro Ellipta or if you become pregnant during treatment. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Breo Ellipta may interact with antifungal medications containing ketoconazole, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, or diuretics.

 

Anoro Ellipta is administered as 1 inhalation dose once daily by the orally inhaled route only.

Breo Ellipta is dosed as 100 mcg/25 mcg once daily. Breo Ellipta is a dry powder for oral inhalation only. Patients with allergies to milk or milk proteins and patients with sensitivities to any component of Breo Ellipta should not use it.